Additional Metadata
Persistent URL dx.doi.org/10.1186/1471-2407-10-247, hdl.handle.net/1765/81766
Journal BMC Cancer
Citation
Dietrich, D, Krispin, M, Dietrich, J, Fassbender, A, Lewin, J, Harbeck, N, … Martens, J.W.M. (2010). CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients. BMC Cancer, 10. doi:10.1186/1471-2407-10-247